Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 196 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 41 | $26.12 | $1,070.92 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,144 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:37 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 20,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 10 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,099 Underlying: Common Stock · 20,099 shares Expires not disclosed F9 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F10 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 9 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,565 Underlying: Common Stock · 2,247 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 8 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,433 Underlying: Common Stock · 1,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 7 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 572 | $26.12 | $14,940.64 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 6 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,998 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 565 | $26.12 | $14,757.80 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 5 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,570 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 924 | $26.12 | $24,134.88 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 4 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,135 F2 · kind: Shares withheld for tax purposes. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 1,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:35 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 19:34 UTC |
Scott Brian M.CFO/COO
|
GrantRestricted Stock Units · Derivative | 26,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-25-000001 · wk-form4_1737142449.xml · derivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,799 Underlying: Common Stock · 26,799 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 18:23 UTC |
Scott Brian M.CFO/COO
|
GrantRestricted Stock Units · Derivative | 37,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000064 · wk-form4_1734459797.xml · derivative · entry 2 Scott Brian M. · CIK 0001510242 · CFO/COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,009 Underlying: Common Stock · 37,009 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on December 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on December 15, 2024 and ending on December 31, 2027 F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 18:23 UTC |
Scott Brian M.CFO/COO
|
GrantRestricted Stock Units · Derivative | 37,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000064 · wk-form4_1734459797.xml · derivative · entry 1 Scott Brian M. · CIK 0001510242 · CFO/COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,009 Underlying: Common Stock · 37,009 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on December 15, 2024 and vest in three tranches on each of the first, second, and third anniversaries of the grant date. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 20:03 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · derivative · entry 6 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,776 Underlying: Common Stock · 2,694 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 20:03 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · derivative · entry 5 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,552 Underlying: Common Stock · 5,389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service. F7 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 20:03 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,022 | $26.29 | $26,868.38 |
DisclosureSEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 4 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,752 F3 · kind: Number of shares withheld for tax purposes. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 20:03 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 3 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Common stock acquired on the vesting of restricted stock units. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 20:03 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,121 | $26.29 | $55,761.09 |
DisclosureSEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 2 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,080 F3 · kind: Number of shares withheld for tax purposes. Read SEC document |
| November 28, 2024 Filed Dec 2, 2024 20:03 UTC |
Grace CarolineDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 5,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 1 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. F2 · balance_after: Includes 470 shares of AMN Common Stock purchased pursuant to the AMN Healthcare Employee Stock Purchase Plan ("ESPP") on March 28, 2024 and 164 shares of AMN Common Stock purchased pursuant to the ESPP on September 30, 2024. Read SEC document |
| November 02, 2024 Filed Nov 4, 2024 23:22 UTC | Exercise / conversionRestricted Stock Units · Derivative | 9,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000057 · wk-form4_1730762538.xml · derivative · entry 3 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,950 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on November 2, 2021 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| November 02, 2024 Filed Nov 4, 2024 23:22 UTC | SaleCommon Stock | 2,461 | $36.90 | $90,810.90 |
DisclosureSEC source: 0001142750-24-000057 · wk-form4_1730762538.xml · nonDerivative · entry 2 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,550 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
|
| November 02, 2024 Filed Nov 4, 2024 23:22 UTC | Exercise / conversionCommon Stock | 9,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000057 · wk-form4_1730762538.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
|
| October 15, 2024 Filed Oct 16, 2024 20:08 UTC | Exercise / conversionRestricted Stock Units · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000054 · wk-form4_1729109331.xml · derivative · entry 3 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,534 Underlying: Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on October 15, 2023 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| October 15, 2024 Filed Oct 16, 2024 20:08 UTC | Tax withholdingCommon Stock | 544 | $40.19 | $21,863.36 |
DisclosureSEC source: 0001142750-24-000054 · wk-form4_1729109331.xml · nonDerivative · entry 2 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,061 F3 · kind: Number of shares withheld for tax purposes. Read SEC document |
|
| October 15, 2024 Filed Oct 16, 2024 20:08 UTC | Exercise / conversionCommon Stock | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000054 · wk-form4_1729109331.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. F2 · balance_after: Includes 218 shares of AMN Common Stock purchased pursuant to the AMN Healthcare Employee Stock Purchase Plan ("ESPP") on March 28, 2024 and 351 shares of AMN Common Stock purchased pursuant to the ESPP on September 30, 2024. Read SEC document |
|
| October 15, 2024 Filed Oct 16, 2024 20:12 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 18,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000056 · wk-form4_1729109524.xml · derivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,661 Underlying: Common Stock · 18,661 shares Expires not disclosed F3 · derivative.exercise_price: Restricted Stock Units do not have an expiration date. F4 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on October 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on October 15, 2024 and ending on December 31, 2027. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 20:12 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 18,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000056 · wk-form4_1729109524.xml · derivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,661 Underlying: Common Stock · 18,661 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 20:10 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 9,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000055 · wk-form4_1729109392.xml · derivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,952 Underlying: Common Stock · 9,952 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on October 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on October 15, 2024 and ending on December 31, 2027. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 20:10 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 9,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000055 · wk-form4_1729109392.xml · derivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,952 Underlying: Common Stock · 9,952 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 14:48 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000052 · wk-form4_1726584493.xml · derivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 981 Underlying: Common Stock · 482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 14:48 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 118 | $47.14 | $5,562.52 |
DisclosureSEC source: 0001142750-24-000052 · wk-form4_1726584493.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,047 Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 14:48 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 482 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000052 · wk-form4_1726584493.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 13:56 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 256 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000051 · wk-form4_1723816555.xml · derivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 256 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on August 15, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 13:56 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 63 | $52.44 | $3,303.72 |
DisclosureSEC source: 0001142750-24-000051 · wk-form4_1723816555.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,683 Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 13:56 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 256 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000051 · wk-form4_1723816555.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| July 22, 2024 Filed Jul 23, 2024 20:47 UTC |
Hinton James H.Director
|
GrantRestricted Stock Units · Derivative | 2,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000044 · wk-form4_1721767637.xml · derivative · entry 1 Hinton James H. · CIK 0001905630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,235 Underlying: Common Stock · 2,235 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on July 22, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| May 20, 2024 Filed May 21, 2024 19:17 UTC |
WHEAT DOUGLAS DDirector
|
GiftCommon Stock | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000041 · wk-form4_1716319030.xml · nonDerivative · entry 1 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,774 F1 · shares: The reporting person transferred 50 shares of AMN Common Stock as a gift. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:27 UTC |
Trent-Adams SylviaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000034 · wk-form4_1713900427.xml · derivative · entry 3 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:27 UTC |
Trent-Adams SylviaDirector
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000034 · wk-form4_1713900427.xml · derivative · entry 2 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:27 UTC |
Trent-Adams SylviaDirector
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000034 · wk-form4_1713900427.xml · nonDerivative · entry 1 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:25 UTC |
FOLETTA MARK GDirector
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000032 · wk-form4_1713900303.xml · derivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:25 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000032 · wk-form4_1713900303.xml · derivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:25 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000032 · wk-form4_1713900303.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:26 UTC |
Fontenot Teri G.Director
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000033 · wk-form4_1713900367.xml · derivative · entry 1 Fontenot Teri G. · CIK 0001661066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:23 UTC |
Jones Daphne EDirector
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000031 · wk-form4_1713900228.xml · derivative · entry 1 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company. F3 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:22 UTC |
Marsh Martha H.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 22,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · derivative · entry 6 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. F10 · derivative.exercise_date: The RSUs were granted on April 18, 2012 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2013 Annual Meeting of Shareholders. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:22 UTC |
Marsh Martha H.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 6,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · derivative · entry 5 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock F8 · derivative.exercise_date: The Restricted Stock Units were granted on September 21, 2010 and vest in the incremental amount of 33% on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; 34% on the earlier of (i) April 13, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 13, 2013 or (ii) the date of the Company's 2013 Annual Meeting of Stockholders. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.